Evaluation of the Zynex Blood Volume Monitor in Healthy Adult Patients During a Blood Draw

Not Applicable

Completed

• Conditions: Blood Loss

• Registration Number: NCT01846195
• Lead Sponsor: Zynex Monitoring Solutions

Brief Summary

Non-invasive monitoring to measure changes in blood volume.

Detailed Description

Not available

Study Timeline

• Study Start: 2012-06-06
• Study First Submitted: 2013-03-13
• Primary Completion: 2013-03-20
• Study Completion: 2013-03-20
• Study First Submitted QC: 2013-04-30
• Study First Posted: 2013-05-03
• Results First Submitted: 2022-08-03
• Status Verified: 2022-10
• Results First Submitted QC: 2022-10-13
• Last Update Submitted: 2022-10-13
• Results First Posted: 2022-11-09
• Last Update Posted: 2022-11-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• Healthy volunteers
• Between 18-35 years of age
• Weight between 130-200 pounds

Exclusion Criteria

• Known cardiac disease
• Recent caffeine intake
• Tobacco use in the (4) hours prior to screening
• Infection
• Pregnancy
• Hemoglobin <13.5 g/dl

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Detect by Non-invasive Monitoring a Change in Blood Volume During a Whole Blood Draw	At study completion (completion of blood draw)	Detection by non-invasive monitoring a change in blood volume (yes or no) during a whole blood draw

Trial Locations

Locations (1)

Premier Research Group; 🇺🇸 Salt Lake City, Utah, United States